Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Opus Genetics, Inc.OCUP · Entity 5892 | Director | June 11, 2024 | June 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Opus Genetics, Inc.
Report date June 11, 2024 · Filed June 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 180,458 |
Reported balance
After 2024-06-11 transaction · row 1
1 source rowRow 1 · 2024-06-11 · Grant · Acquired 41,143 · Balance 180,458 F1: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.72 · Expires 2034-06-10 | Direct | 35,181 |
Reported balance
After 2024-06-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-06-11 · Grant · Acquired 35,181 · Balance 35,181 F2: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
F2: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2024 Filed Jun 13, 2024 17:30 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantStock Option (Right to Buy) · Derivative | 35,181 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0000905148-24-001713 · form4.xml · derivative · entry 2 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,181 Underlying: Common Stock · 35,181 shares Expires 2034-06-10 F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 17:30 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 41,143 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001713 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,458 F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 16:11 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantStock Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0000905148-24-001166 · form4.xml · derivative · entry 2 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2034-04-10 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments beginning on May 11, 2024, subject to the Reporting Person's continuing service. Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 16:11 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001166 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,315 F1 · shares: Represents a grant of restricted stock units which vest on the one-year anniversary of the grant date of April 11, 2024, subject to the Reporting Person's continuing service. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 18:06 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 14,964 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-000498 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,315 F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for 2024. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $2.81 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 1, 2024. Read SEC document |
| November 01, 2023 Filed Nov 13, 2023 17:46 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-052988 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,351 F1 · shares: Represents a grant of restricted stock units, which vest on the one-year anniversary of the date of grant. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 18:49 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantStock Option · Derivative | 9,639 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001140361-23-029022 · form4.xml · derivative · entry 2 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,639 Underlying: Common Stock · 9,639 shares Expires 2033-06-05 F2 · derivative.exercise_date: Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 18:49 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 10,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-029022 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,351 F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 20:20 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 468 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-019674 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,375 F1 · price: The Reporting Person was granted shares of common stock in lieu of incremental cash amounts for board services for 2023. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $4.27 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to April 19, 2023. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 17:34 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 13,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-001516 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,907 F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for 2023. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $3.07 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 11, 2023. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 17:34 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantStock Option (right to buy) · Derivative | 33,291 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001140361-23-001516 · form4.xml · derivative · entry 2 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,291 Underlying: Common Stock · 33,291 shares Expires 2033-01-09 F2 · derivative.exercise_date: The option will vest with respect to 8,322 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:36 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantCommon Stock | 9,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-025282 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,894 F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for the second half of 2022. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $2.02 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to July 1, 2022. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 16:01 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-023048 · form4.xml · derivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-12 F1 · derivative.exercise_date: Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 08, 2022 Filed Apr 13, 2022 13:56 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001140361-22-014327 · form4.xml · derivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-04-07 F1 · derivative.exercise_date: The option will vest with respect to 12,500 shares on March 31, 2023, and then with respect to 1,041 shares on the last day of each month from April 2023 through February 2026 and with respect to 1,065 shares at the end of March 2026, subject to the Reporting Person's continuing service through each applicable vesting date. Read SEC document |
| December 13, 2021 Filed Dec 14, 2021 20:44 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | PurchaseCommon Stock | 8,250 | $3.65 | $30,112.50 |
DisclosureSEC source: 0001140361-21-041622 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,994 Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 08:00 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | PurchaseCommon Stock | 12,631 | $4.75 | $59,997.25 |
DisclosureSEC source: 0001140361-21-031308 · form4.xml · nonDerivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,744 Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:21 UTC | Opus Genetics, Inc. OCUP · Entity 5892 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $5.74 | $0.00 |
DisclosureSEC source: 0001140361-21-020425 · form4.xml · derivative · entry 1 Pepose Jay · CIK 0001866191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-06-07 F1 · derivative.exercise_date: Will vest in a series of three successive equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's continuing service through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.